A ultra-stable point of care nanozyme-based kit for cTnI detection in human serum
Home discovery of myocardial infarction can significantly improve the rate of treatment. Cardiac troponin I (cTnI), as a biochemical marker that has been introduced into clinical diagnosis and treatment guidelines, can effectively predict the occurrence of myocardial infarction. We constructed highl...
Saved in:
| Main Authors: | Mingfei Sun, Zhan Yang, Ziwei Ma, Jinbo Wu, Shaoying Lu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Bioengineering and Biotechnology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2025.1570668/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of some heart enzymes and Iron levels in β-thalassemia patients in Thi-Qar City, Iraq
by: Ahmed jaber ibrahim, et al.
Published: (2024-06-01) -
Evaluation of the Use of Different Sensitive Cardiac Biomarkers in Determining Myocardial Damage in Cows With Subclinical and Clinical Ketoses
by: Murat Uztimür, et al.
Published: (2025-05-01) -
Sustainable nanozymes: recent trends and future directions
by: Dong Hoon Lee, et al.
Published: (2025-01-01) -
Recent Advances in Nanozymes for the Treatment of Atherosclerosis
by: Zou Z, et al.
Published: (2025-07-01) -
Nanozymes with phosphatase-like activity
by: Yu Cao, et al.
Published: (2025-08-01)